Rimegepant
|
- $43 - $15225
- Product name: Rimegepant
- CAS: 1289023-67-1
- MF: C28H28F2N6O3
- MW: 534.56
- EINECS:
- MDL Number:MFCD23098777
- Synonyms:4-(2,3-Dihydro-2-oxo-1H-imidazo[4,5-b]pyridin-1-yl)-1-piperidinecarboxylic acid (5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl ester;Rimegepant;CS-2806;BMS-927711(Rimegepant);BMS 92771;RIMEGEPANT;BMS-927711;BMS927711;BMS 92771;(5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate;1-Piperidinecarboxylic acid, 4-(2,3-dihydro-2-oxo-1H-imidazo[4,5-b]pyridin-1-yl)-, (5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl ester
22 prices
Selected condition：
Brand
- American Custom Chemicals Corporation
- ApexBio Technology
- Biorbyt Ltd
- Cayman Chemical
- ChemScene
- Crysdot
- DC Chemicals
- Medical Isotopes, Inc.
- TRC
Package
- 1mg
- 2mg
- 5MG
- 10mg
- 25mg
- 50mg
- 100mg
- 250mg
- 500mg
- 1g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberAPI0045899
- Product description4-(2,3-DIHYDRO-2-OXO-1H-IMIDAZO[4,5-B]PYRIDIN-1-YL)-1-PIPERIDINECARBOXYLIC ACID (5S,6S,9R)-5-AMINO-6-(2,3-DIFLUOROPHENYL)-6,7,8,9-TETRAHYDRO-5H-CYCLOHEPTA[B]PYRIDIN-9-YL ESTER 95.00%
- Packaging5MG
- Price$495.23
- Updated2021-12-16
- Buy
- ManufacturerApexBio Technology
- Product numberA3259
- Product descriptionBMS-927711
- Packaging2mg
- Price$173
- Updated2021-12-16
- Buy
- ManufacturerApexBio Technology
- Product numberA3259
- Product descriptionBMS-927711
- Packaging5mg
- Price$299
- Updated2021-12-16
- Buy
- ManufacturerApexBio Technology
- Product numberA3259
- Product descriptionBMS-927711
- Packaging10mg
- Price$457
- Updated2021-12-16
- Buy
- ManufacturerApexBio Technology
- Product numberA3259
- Product descriptionBMS-927711
- Packaging50mg
- Price$1496
- Updated2021-12-16
- Buy
- ManufacturerBiorbyt Ltd
- Product numberorb573258
- Product descriptionBMS-927711(Rimegepant) >98%
- Packaging100mg
- Price$1283.5
- Updated2021-12-16
- Buy
- ManufacturerBiorbyt Ltd
- Product numberorb573258
- Product descriptionBMS-927711(Rimegepant) >98%
- Packaging250mg
- Price$2245.7
- Updated2021-12-16
- Buy
- ManufacturerBiorbyt Ltd
- Product numberorb573258
- Product descriptionBMS-927711(Rimegepant) >98%
- Packaging1g
- Price$4321.4
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number26338
- Product descriptionRimegepant
- Packaging1mg
- Price$43
- Updated2023-06-20
- Buy
- ManufacturerCayman Chemical
- Product number26338
- Product descriptionRimegepant
- Packaging5mg
- Price$189
- Updated2023-06-20
- Buy
- ManufacturerCayman Chemical
- Product number26338
- Product descriptionRimegepant
- Packaging10mg
- Price$334
- Updated2023-06-20
- Buy
- ManufacturerCayman Chemical
- Product number26338
- Product descriptionRimegepant
- Packaging25mg
- Price$678
- Updated2023-06-20
- Buy
- ManufacturerChemScene
- Product numberCS-1027
- Product descriptionRimegepant 99.08%
- Packaging5mg
- Price$140
- Updated2021-12-16
- Buy
- ManufacturerChemScene
- Product numberCS-1027
- Product descriptionRimegepant 99.08%
- Packaging10mg
- Price$240
- Updated2021-12-16
- Buy
- ManufacturerChemScene
- Product numberCS-1027
- Product descriptionRimegepant 99.08%
- Packaging50mg
- Price$750
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD31003993
- Product descriptionBMS-927711 98+%
- Packaging5mg
- Price$176
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | API0045899 | 4-(2,3-DIHYDRO-2-OXO-1H-IMIDAZO[4,5-B]PYRIDIN-1-YL)-1-PIPERIDINECARBOXYLIC ACID (5S,6S,9R)-5-AMINO-6-(2,3-DIFLUOROPHENYL)-6,7,8,9-TETRAHYDRO-5H-CYCLOHEPTA[B]PYRIDIN-9-YL ESTER 95.00% | 5MG | $495.23 | 2021-12-16 | Buy |
| ApexBio Technology | A3259 | BMS-927711 | 2mg | $173 | 2021-12-16 | Buy |
| ApexBio Technology | A3259 | BMS-927711 | 5mg | $299 | 2021-12-16 | Buy |
| ApexBio Technology | A3259 | BMS-927711 | 10mg | $457 | 2021-12-16 | Buy |
| ApexBio Technology | A3259 | BMS-927711 | 50mg | $1496 | 2021-12-16 | Buy |
| Biorbyt Ltd | orb573258 | BMS-927711(Rimegepant) >98% | 100mg | $1283.5 | 2021-12-16 | Buy |
| Biorbyt Ltd | orb573258 | BMS-927711(Rimegepant) >98% | 250mg | $2245.7 | 2021-12-16 | Buy |
| Biorbyt Ltd | orb573258 | BMS-927711(Rimegepant) >98% | 1g | $4321.4 | 2021-12-16 | Buy |
| Cayman Chemical | 26338 | Rimegepant | 1mg | $43 | 2023-06-20 | Buy |
| Cayman Chemical | 26338 | Rimegepant | 5mg | $189 | 2023-06-20 | Buy |
| Cayman Chemical | 26338 | Rimegepant | 10mg | $334 | 2023-06-20 | Buy |
| Cayman Chemical | 26338 | Rimegepant | 25mg | $678 | 2023-06-20 | Buy |
| ChemScene | CS-1027 | Rimegepant 99.08% | 5mg | $140 | 2021-12-16 | Buy |
| ChemScene | CS-1027 | Rimegepant 99.08% | 10mg | $240 | 2021-12-16 | Buy |
| ChemScene | CS-1027 | Rimegepant 99.08% | 50mg | $750 | 2021-12-16 | Buy |
| Crysdot | CD31003993 | BMS-927711 98+% | 5mg | $176 | 2021-12-16 | Buy |
Properties
Density :1.45±0.1 g/cm3(Predicted)
storage temp. :Store at -20°C
solubility :Soluble in DMSO
form :A crystalline solid
pka :12.03±0.20(Predicted)
storage temp. :Store at -20°C
solubility :Soluble in DMSO
form :A crystalline solid
pka :12.03±0.20(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|
Description
Rimegepant (Nurtec ODT)(FDA approved in February 2020) is an ODT available in a single strength of 75 mg for the acute treatment of migraine with or without aura in adults.No more than 75 mg should be taken in a 24-hour period. while there are no contraindications，concomitant administration with CYP3A4 inhibitors should be avoided.The most common adverse reaction is nausea, occurring in few patients (rimegepant PI, 2020). In clinical trials, a single 75-mg dose of rimegepant demonstrated superiority over placebo with regard to freedom from pain (21% in the rimegepant group vs.11% in the placebo group) and freedom from the most bothersome symptom (35% vs. 27%) at 2 hours post dose (Croop et al., 2019). Rimegepant is not approved for migraine prevention, although it is presently in late-stage clinical trials assessing it for that indication(NCT03732638,2020).Suppliers and manufacturers
Changsha Junyu Chemexpress.co., Ltd
Senova Technology Co. Ltd.
Jinan Carbotang Biotech Co.,Ltd.
SHANGHAI T&W PHARMACEUTICAL CO., LTD.
HANGZHOU CLAP TECHNOLOGY CO.,LTD
Shanghai UCHEM Inc.
Hangzhou Cherry Pharmaceutical Technology Co.,ltd
